TipRanks
Advertisement
Advertisement

HK:3378 Stock Latest News

Hanx Biopharmaceuticals Taps XtalPi’s AI Platform to Accelerate Drug R&D
Company AnnouncementsHanx Biopharmaceuticals Taps XtalPi’s AI Platform to Accelerate Drug R&D
14d ago
3378
Hanx Biopharmaceuticals Plans HK$486 Million Warrant Financing for R&D and Working Capital
PremiumCompany Announcements
Hanx Biopharmaceuticals Plans HK$486 Million Warrant Financing for R&D and Working Capital
22d ago
3378
Hanx Biopharmaceuticals narrows interim loss as oncology pipeline advances
PremiumCompany Announcements
Hanx Biopharmaceuticals narrows interim loss as oncology pipeline advances
2M ago
3378
Hanx Biopharmaceuticals Sets Board Meeting to Approve Interim 2026 Results
PremiumCompany Announcements
Hanx Biopharmaceuticals Sets Board Meeting to Approve Interim 2026 Results
2M ago
3378
PremiumCompany Announcements
Hanx Biopharmaceuticals Launches AI-Driven Drug Discovery Collaboration
3M ago
3378
Hanx Biopharmaceuticals launches AI-driven collaboration to accelerate HX009 lymphoma drug development
PremiumCompany AnnouncementsHanx Biopharmaceuticals launches AI-driven collaboration to accelerate HX009 lymphoma drug development
3M ago
3378
Hanx Biopharmaceuticals Investors Voluntarily Extend Share Lock-Up Periods
Premium
Company Announcements
Hanx Biopharmaceuticals Investors Voluntarily Extend Share Lock-Up Periods
3M ago
3378
Hanx Biopharmaceuticals AGM Backs Governance, Auditor and Profit Plan
Premium
Company Announcements
Hanx Biopharmaceuticals AGM Backs Governance, Auditor and Profit Plan
3M ago
3378
Hanx Biopharmaceuticals Added to FTSE Global Micro Cap Index, Boosting Global Profile
PremiumCompany Announcements
Hanx Biopharmaceuticals Added to FTSE Global Micro Cap Index, Boosting Global Profile
4M ago
3378
Hanx Biopharmaceuticals Sets 2026 AGM to Approve Results, Profit Plan and Share Mandate
PremiumCompany Announcements
Hanx Biopharmaceuticals Sets 2026 AGM to Approve Results, Profit Plan and Share Mandate
4M ago
3378
Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Causeway Bay
PremiumCompany Announcements
Hanx Biopharmaceuticals Relocates Hong Kong Principal Office to Causeway Bay
4M ago
3378
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Drugs at 2026 AACR Meeting
PremiumCompany Announcements
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Drugs at 2026 AACR Meeting
5M ago
3378
Hanx Biopharmaceuticals Showcases Next-Generation Cancer Pipeline at 2026 AACR Meeting
PremiumCompany AnnouncementsHanx Biopharmaceuticals Showcases Next-Generation Cancer Pipeline at 2026 AACR Meeting
6M ago
3378
Hanx Biopharmaceuticals Deepens R&D Push as 2025 Loss Widens on Pipeline Expansion
Premium
Company Announcements
Hanx Biopharmaceuticals Deepens R&D Push as 2025 Loss Widens on Pipeline Expansion
6M ago
3378
Hanx Biopharmaceuticals Raises Caps on Connected Raw Material Purchases
Premium
Company Announcements
Hanx Biopharmaceuticals Raises Caps on Connected Raw Material Purchases
6M ago
3378
Hanx Biopharmaceuticals Expands Business Scope With Proposed Articles Amendments
PremiumCompany Announcements
Hanx Biopharmaceuticals Expands Business Scope With Proposed Articles Amendments
6M ago
3378
Hanx Biopharmaceuticals Sets March Board Meeting to Approve 2025 Results and Consider Dividend
PremiumCompany Announcements
Hanx Biopharmaceuticals Sets March Board Meeting to Approve 2025 Results and Consider Dividend
7M ago
3378
Hanx Biopharmaceuticals Wins Shareholder Approval for H-Share Buyback Mandate
PremiumCompany Announcements
Hanx Biopharmaceuticals Wins Shareholder Approval for H-Share Buyback Mandate
8M ago
3378
Hanx Biopharmaceuticals Sets Out Board and Committee Structure
PremiumCompany Announcements
Hanx Biopharmaceuticals Sets Out Board and Committee Structure
8M ago
3378
Hanx Biopharmaceuticals Elevates Xiao Jieyu to Executive Director, Consolidating Finance and Governance Roles
PremiumCompany AnnouncementsHanx Biopharmaceuticals Elevates Xiao Jieyu to Executive Director, Consolidating Finance and Governance Roles
8M ago
3378
Hanx Biopharmaceuticals Doses First Patient in First-in-Class OX40 ADC Trial
Premium
Company Announcements
Hanx Biopharmaceuticals Doses First Patient in First-in-Class OX40 ADC Trial
8M ago
3378
Hanx Biopharmaceuticals Seeks Shareholder Mandate for Up to 10% H-Share Buyback
Premium
Company Announcements
Hanx Biopharmaceuticals Seeks Shareholder Mandate for Up to 10% H-Share Buyback
8M ago
3378

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >